Anti-NKG2A Anticorps (A323588)

Monalizumab Biosimilar - Anti-NKG2A Antibody - Low endotoxin, Azide free

Recombinant humanized monoclonal antibody to NKG2A.

ELISA, FACS, Functional Assay, In Vivo

Human, Rhesus Macaque, Cynomolgus Macaque, Baboon

Humanized

Monoclonal

IgG4

kappa

Unconjugated

Protein A affinity chromatography.

Reconstitution dependent.

> 90% (by SDS-PAGE and SEC-HPLC).

Lyophilized

Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!

Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.

Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.

C lectin type II protein, CD159 antigen like family member A, CD159 antigen-like family member A, CD159a, CD159a antigen, Killer cell lectin like receptor subfamily C member 1, KLRC1, MGC13374, MGC59791, Natural killer cell lectin, Natural killer cell protein group 2-A1, Natural killer cell receptor NKG2A, Natural killer group protein 2, NK cell receptor A, NKG2, NKG2 1/B activating NK receptor, NKG2 A, NKG2 A/B activating NK receptor, NKG2 A/B type II integral membrane protein, NKG2 A/NKG2 B type II integral membrane protein, NKG2 B, NKG2-1/B activating NK receptor, NKG2-A/B-activating NK receptor, NKG2-A/NKG2-B type II integral membrane protein, NKG2A_HUMAN, NKG2B, rNKG2A